共 88 条
[1]
Barker JN(2019)Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis Blood Adv 3 939-44
[2]
Boughan K(2020)Evaluation of cord blood total nucleated and CD34(+) cell content, cell dose, and 8-allele HLA match by patient ancestry Biol Blood Marrow Transplant 26 734-44
[3]
Dahi PB(2017)Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies Biol Blood Marrow Transplant 23 882-96
[4]
Devlin SM(2019)Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR Blood 134 924-34
[5]
Maloy MA(2014)Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice Blood 124 2905-12
[6]
Naputo K(2017)Cryopreserved CD34(+) cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients Biol Blood Marrow Transplant 23 1142-50
[7]
Barker JN(2002)Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival Blood 100 1611-8
[8]
Mazis CM(2019)CD34(+) cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking Blood Adv 3 1267-71
[9]
Devlin SM(2011)Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood Cytotherapy 13 848-55
[10]
Davis E(2012)The use of back-up units to enhance the safety of unrelated donor cord blood transplantation Biol Blood Marrow Transplant 18 648-51